Findings reveal that mitochondrial D-loop methylation distinguishes Parkinson’s disease from atypical parkinsonism, indicating unique disease mechanisms.
Decreased mitochondrial D-loop methylation in PD-D and APS may reflect disease-specific epigenetic mechanisms rather than clinical characteristics or treatment effects.
No takes yet. Share an insight, caveat, or question.
Karacicek et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: